Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 12, Pages 492
Publisher
MDPI AG
Online
2018-12-06
DOI
10.3390/cancers10120492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis
- (2018) Dimitrios E. Magouliotis et al. ACTA NEUROCHIRURGICA
- Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial
- (2018) H -G Wirsching et al. ANNALS OF ONCOLOGY
- Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis
- (2018) Liang Xia et al. BMC CANCER
- CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
- (2018) Brooke L. Prinzing et al. Expert Review of Anticancer Therapy
- Highlighting the need for reliable clinical trials in glioblastoma
- (2018) Jacob J. Mandel et al. Expert Review of Anticancer Therapy
- Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma
- (2018) Soumon Rudra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Translational gap in ongoing clinical trials for glioma
- (2018) Alecia Florence Guishard et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Ten-year survival in glioblastoma. A systematic review
- (2018) Tomasz Tykocki et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
- (2018) Alyssa M Vanderbeek et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis
- (2018) Sara Hanaei et al. REVIEWS IN THE NEUROSCIENCES
- Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis
- (2018) Jie Song et al. OncoTargets and Therapy
- Results of a Policy of Fast Tapering of Steroids After Resection Surgery in Glioblastoma
- (2018) Ricardo Díez Valle et al. World Neurosurgery
- Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
- (2018) Serena Pellegatta et al. OncoImmunology
- Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
- (2018) Yu Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bevacizumab and Glioblastoma
- (2018) Michelle M. Kim et al. CANCER JOURNAL
- A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
- (2018) Aleksei A. Stepanenko et al. GENE
- Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
- (2018) Joshua D. Palmer et al. JOURNAL OF NEURO-ONCOLOGY
- Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
- (2018) Martin J van den Bent et al. LANCET ONCOLOGY
- First results on the DCVax phase III trial: raising more questions than providing answers
- (2018) Wolfgang Wick et al. NEURO-ONCOLOGY
- Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
- (2018) Aleksei A. Stepanenko et al. VIRUS RESEARCH
- Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
- (2018) Stefan-Alexandru Artene et al. Scientific Reports
- Immunotherapy in Glioblastoma
- (2018) Jessica A. Wilcox et al. World Neurosurgery
- Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials
- (2018) Zhouqing Chen et al. Cancer Management and Research
- The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
- (2018) Ibrahim Eissa et al. Cancers
- Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
- (2018) E Antonio Chiocca et al. NEURO-ONCOLOGY
- Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
- (2018) Johanna Buchroithner et al. Cancers
- Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance
- (2017) Ourania N. Kostopoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature
- (2017) Matthew Tipping et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The use of isoflurane and desflurane as inhalational agents for glioblastoma surgery. A survival analysis
- (2017) J.P. Cata et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge
- (2017) Ali Naboush et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
- (2017) J. Duerinck et al. JOURNAL OF NEURO-ONCOLOGY
- Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
- (2017) Myra E. van Linde et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
- (2017) Susana Inogés et al. Journal of Translational Medicine
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Go, no-go decision making for phase 3 clinical trials: ACT IV revisited
- (2017) Huy Tram N Nguyen et al. LANCET ONCOLOGY
- Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients
- (2017) Tae Hoon Roh et al. MEDICINE
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
- (2017) Jacob J Mandel et al. NEURO-ONCOLOGY
- Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
- (2017) Deborah T. Blumenthal et al. NEURO-ONCOLOGY
- Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
- (2017) Tiffany R. Hodges et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma
- (2017) Dorothee Gramatzki et al. NEUROLOGY
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma
- (2017) Marco Skardelly et al. ONCOLOGIST
- Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov
- (2017) Nikola Cihoric et al. Radiation Oncology
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- DNA Damage and Repair Biomarkers of Immunotherapy Response
- (2017) Kent W. Mouw et al. Cancer Discovery
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis
- (2017) Weilin Xu et al. Oncotarget
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme
- (2017) Giannis Sokratous et al. Human Vaccines & Immunotherapeutics
- Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
- (2017) Giulia Viale et al. Biomed Research International
- In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
- (2017) Guranda Chitadze et al. OncoImmunology
- The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8 + T Cell Anti-tumor Activity
- (2017) Anne Kleijn et al. Molecular Therapy-Oncolytics
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Corticosteroids compromise survival in glioblastoma
- (2016) Kenneth L. Pitter et al. BRAIN
- The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
- (2016) Xiaozhu Li et al. CLINICAL CANCER RESEARCH
- Therapeutic options in recurrent glioblastoma—An update
- (2016) Katharina Seystahl et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- (2016) Shinichi Watanabe et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A critical balance: managing coagulation in patients with glioma
- (2016) Erin R. Morgan et al. Expert Review of Neurotherapeutics
- Chemoradiation-Related Lymphopenia Is Common Among Glioblastoma Patients and Is Associated With Worse Progression-Free and Overall Survival
- (2016) R. Rahman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- What Happens When Underperforming Big Ideas in Research Become Entrenched?
- (2016) Michael J. Joyner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Venous thromboembolism in brain tumor patients
- (2016) David J. Cote et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
- (2016) Caroline Happold et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide
- (2016) Navid Redjal et al. JOURNAL OF NEURO-ONCOLOGY
- Does the choice of antiepileptic drug affect survival in glioblastoma patients?
- (2016) Kristin M. Knudsen-Baas et al. JOURNAL OF NEURO-ONCOLOGY
- Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
- (2016) Joe S. Mendez et al. JOURNAL OF NEURO-ONCOLOGY
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- Limits to Personalized Cancer Medicine
- (2016) Ian F. Tannock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecularly Targeted Drugs Plus Radiotherapy and Temozolomide Treatment for Newly Diagnosed Glioblastoma: A Meta-Analysis and Systematic Review
- (2016) Jiahao Su et al. ONCOLOGY RESEARCH
- Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
- (2016) Abhishek D. Garg et al. Science Translational Medicine
- Recurrent venous thromboembolism in glioblastoma
- (2016) Natasha Catherine Edwin et al. THROMBOSIS RESEARCH
- Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review
- (2016) Lynn S. Ashby et al. World Journal of Surgical Oncology
- Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
- (2016) T. M. Johanns et al. Cancer Discovery
- Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
- (2016) Doo-Sik Kong et al. Oncotarget
- A critical balance: managing coagulation in patients with glioma
- (2016) Erin R. Morgan et al. Expert Review of Neurotherapeutics
- TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
- (2016) M. S. Hsu et al. Cancer Immunology Research
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
- (2015) E T Wong et al. BRITISH JOURNAL OF CANCER
- Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
- (2015) Young-Hoon Kim et al. CANCER
- Prognostic implications of epilepsy in glioblastomas
- (2015) Manuel Toledo et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Venous thrombosis in patients with high-grade glioma
- (2015) Sophie Taillibert et al. CURRENT OPINION IN ONCOLOGY
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
- (2015) Minh Thi Tieu et al. JOURNAL OF NEURO-ONCOLOGY
- Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
- (2015) Marcos A. dos Santos et al. JOURNAL OF NEURO-ONCOLOGY
- Heparin in malignant glioma: review of preclinical studies and clinical results
- (2015) Rosalie Schnoor et al. JOURNAL OF NEURO-ONCOLOGY
- A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors
- (2015) Michael B. Streiff et al. JOURNAL OF NEURO-ONCOLOGY
- Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
- (2015) Sajeel A. Chowdhary et al. JOURNAL OF NEURO-ONCOLOGY
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
- (2015) David A. Reardon et al. NEURO-ONCOLOGY
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Prognostic relevance of epilepsy at presentation in glioblastoma patients
- (2015) Sharon Berendsen et al. NEURO-ONCOLOGY
- Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis
- (2015) S. A. Almenawer et al. NEURO-ONCOLOGY
- Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
- (2015) Lisa B. E. Shields et al. Radiation Oncology
- The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis
- (2015) Zhen-yu Qi et al. Drug Design Development and Therapy
- Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
- (2015) Alistair M. Cook et al. OncoImmunology
- Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
- (2014) Xuan Wang et al. CANCER INVESTIGATION
- A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma
- (2014) W. Wick et al. CLINICAL CANCER RESEARCH
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Hypofractionated stereotactic reirradiation for recurrent glioblastoma
- (2014) Gozde Yazici et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
- (2014) Charles J. Vecht et al. ONCOLOGIST
- Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis
- (2014) Jun-Xia Cao et al. PLoS One
- Survival analysis for valproic acid use in adult glioblastoma multiforme: A meta-analysis of individual patient data and a systematic review
- (2014) Yang Yuan et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
- (2014) Sadhak Sengupta et al. Biomed Research International
- Sustained CD4+T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide
- (2014) Susannah Ellsworth et al. OncoImmunology
- Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
- (2013) Signe Regner Michaelsen et al. BMC CANCER
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
- (2013) Sara Fritzell et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells
- (2013) Susannah Yovino et al. CANCER INVESTIGATION
- Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: A clinical audit
- (2013) Tejpal Gupta et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- The treatment of glioblastomas: A systematic update on clinical Phase III trials
- (2013) An-an Yin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The role of Gliadel wafers in the treatment of high-grade gliomas
- (2013) Amade Bregy et al. Expert Review of Anticancer Therapy
- Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
- (2013) Christopher A. Barker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Steroid management in newly diagnosed glioblastoma
- (2013) Mariel B. Deutsch et al. JOURNAL OF NEURO-ONCOLOGY
- Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme
- (2013) M. Kerkhof et al. NEURO-ONCOLOGY
- Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience
- (2013) Patrizia Ciammella et al. Radiation Oncology
- Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment
- (2013) Jordi Bruna et al. Expert Review of Clinical Pharmacology
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Survival of children with malignant brain tumors receiving valproate: a retrospective study
- (2012) F. H. C. Felix et al. CHILDS NERVOUS SYSTEM
- Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
- (2012) Sadhak Sengupta et al. Clinical & Developmental Immunology
- A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
- (2012) J. R. Tysome et al. CLINICAL CANCER RESEARCH
- Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas
- (2012) Filip Y. De Vos et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme
- (2012) Greg D. Guthrie et al. JOURNAL OF NEUROSURGERY
- The Role of BCNU Polymer Wafers (Gliadel) in the Treatment of Malignant Glioma
- (2012) Seema Nagpal NEUROSURGERY CLINICS OF NORTH AMERICA
- The kaleidoscope of glucorticoid effects on immune system
- (2011) Margherita Zen et al. AUTOIMMUNITY REVIEWS
- Effect of valproic acid on the outcome of glioblastoma multiforme
- (2011) Hong-Chieh Tsai et al. BRITISH JOURNAL OF NEUROSURGERY
- Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
- (2011) Amy S. Darefsky et al. CANCER
- Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
- (2011) X. Jie et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
- (2011) C. E. Fadul et al. NEURO-ONCOLOGY
- Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and Histology
- (2011) Kimberly R. Porter et al. NEUROEPIDEMIOLOGY
- Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
- (2011) M. Weller et al. NEUROLOGY
- Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
- (2011) Der-Yang Cho et al. World Neurosurgery
- Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors
- (2010) Sara Mariucci et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
- (2010) Michael Brada et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
- (2010) Agnes E. Coutinho et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
- (2010) Michael P. Gustafson et al. NEURO-ONCOLOGY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- Low Peripheral Lymphocyte Count Before Focal Radiotherapy Plus Concomitant Temozolomide Predicts Severe Lymphopenia During Malignant Glioma Treatment
- (2010) Eiichi ISHIKAWA et al. NEUROLOGIA MEDICO-CHIRURGICA
- Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
- (2009) Robert Owen Dillman et al. JOURNAL OF IMMUNOTHERAPY
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy of anti-epileptic drugs in patients with gliomas and seizures
- (2009) Mèlanie S. M. Breemen et al. JOURNAL OF NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Hypofractionated Stereotactic Reirradiation of Recurrent Glioblastomas
- (2009) Emmanouil Fokas et al. STRAHLENTHERAPIE UND ONKOLOGIE
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- (2008) S. De Vleeschouwer et al. CLINICAL CANCER RESEARCH
- Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
- (2008) James F. Curtin et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started